Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 189articles · 30d
- 8+ hour agolatest article
- Aug 14, 2026earliest in window
- 89%with images
- 245avg words
- Medical 139
- Health & Wellness 102
- Economy, Business & Finance 81
- Health 75
- Business & Industrial 65
- Finance & Business 33
- Science & Technology 21
- News 15
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate
4+ day, 2+ hour ago (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...
Neurizon appoints Dr. Chris Bremer as CEO
4+ day, 2+ hour ago (277+ words) Neurizon Therapeutics has appointed Dr. Chris Bremer as Chief Executive Officer, effective October 1, 2026 while the Australian biotechnology company advances its lead ALS drug candidate NUZ-001. Dr. Bremer will initially serve as CEO and will not join the board of Neurizon…...
Biocon inks 10-year deal to supply breast cancer therapy to Brazil
4+ day, 20+ hour ago (256+ words) Biocon Limited has signed a landmark partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil. This collaboration marks a significant step forward in scaling the production and commercialization of this HER2-positive breast cancer therapy under the country's Productive Development…...
Novartis’ pelacarsen trial fails to cut cardiovascular risk
4+ day, 22+ hour ago (54+ words) The pivotal cardiovascular outcomes trial did not meet its primary endpoint FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut cardiovascular risk Indian…...
Superluminal Medicines raises $60 million to push obesity drug into clinic
5+ day, 3+ hour ago (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...
AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56%
6+ day, 1+ hour ago (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...
Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial
6+ day, 22+ hour ago (68+ words) Indian Pharma Post Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The…...
Gan & Lee signs up to €726 million Menarini deal for obesity drug in Europe
1+ week, 4+ hour ago (61+ words) The deal gives Gan & Lee a major European partner as the Chinese pharmaceutical company seeks to turn bofanglutide into a global metabolic-health product Priyanka Tewari appointed Head of Marketing at Glenmark Pharma Sonika Natalkar joins Lupin as Deputy General Manager…...
AstraZeneca completes Dizal deal for lung cancer drug Zegfrovy
1+ week, 3+ day ago (60+ words) The deal gives AstraZeneca global control of a drug targeting a particularly aggressive form of lung cancer with significant unmet treatment needs Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical…...
Novartis’ Remibrutinib delivers positive Phase III results in relapsing multiple sclerosis
1+ week, 3+ day ago (47+ words) The results point to potential benefits beyond relapse control Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical imaging network India Glycols demerges biopharma business into separate entity Dr. Vineet Talwar…...